SE412394B

Catalytic asymmetric hydrogenation and catalyst therefor

Abstract

Asymetric hydrogenation of beta-substd.-alpha-acylamidoacrylic acrds or their salts is carried out in the presence of a co-ordination complex of rhodium, iridium, ruthenium, osmium, palladium or platinium with at least one optically active phosphine or arsine cpd. The reaction may be used for producing L-DOPA, an anti-parkinson agent.

SE412394B, drawing sheet 1
Sheet 1 of 32

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

4 claims: 1 independent, 3 dependent

  1. 1
    Patentkrav claim 1. Förening till användning som katalysator för asymmetrisk hydrering av β-substituerade a-acylamido-akrylsyror och/eller salter därav, kännetecknad av att den består av ett rodiumkoordinationskomplex med minst en optiskt aktiv fosfinligand, vilket komplex har formeln RhXnL^, där X representerar H, Cl, F, Br eller I, n är 1 eller 3 och Lj representerar tre fosfinligander, av vilka åtminstone en är optiskt aktiv och innehåller en o-anisylgrupp. 1st Compound for use as a catalyst for asymmetric hydrogenation of β-substituted α-acylamido acrylic acids and / or salts thereof, characterized in that it consists of a rhodium coordination complex with at least one optically active phosphine ligand, which complex has the formula RhXnL 2, where X represents H, Cl, F, Br or I, n is 1 or 3 and Lj represents three phosphine ligands, at least one of which is optically active and contains an o-anisyl group.